The CVC market is projected to grow from USD 2,861.0 million in 2024 to USD 5,436.8 million by 2034 at a CAGR of 6.6%.

“As the market leader in both Central Venous Catheters (CVCs) 1 and Arterials 2, we are pleased to offer Vizient provider-customers one of the broadest portfolios of vascular access products ...

and 2 mg to clear clots in central venous catheters pending the results of a study to determine the effectiveness of smaller doses.

Read about how Northern Ireland nurses are pioneering a new way of inserting catheters, to improve waiting times and patient ...

Most participants (53.8%) had three or more coexisting medical conditions, and 41.0% had previously undergone central venous catheter placement. The inserted PICCs in this trial were most commonly ...

CVC = Central venous catheter; SBP = Systolic blood pressure Adapted with permission from [7,11,12]. Jean-Luc Pagani and Philippe Eggimann, Department of Adult Intensive Care Medicine & Burn ...

Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study ...

Clinical Analytics tools are widely used by large healthcare systems including those with a narrow focus on orthopedic and rehabilitation care surgical care pediatrics and so on These healthcare syste ...

Servier Egypt, a leading player in the pharmaceutical industry and part of the global Servier Group, proudly marked its ...

CASCADE, Central venous Access device SeCurement And Dressing Effectiveness; PICC, Peripherally inserted central catheter; nt, non-tunnelled; t, tunnelled. Sample size estimates: A reduction in ...

Effective January 1, 2025, the agreement grants Vizient’s members access to Teleflex’s Central Venous Access Catheters and Arterial Catheters under pre-negotiated terms, enhancing cost ...